“…Every year, millions of people around the world suffer from tissue loss and end-stage organ failure, which has been one of major health care challenges in every country. , Traditional strategies, including tissue or organ transplants, surgical reconstructions, mechanical devices, etc., are limited by donor shortages, immune rejection, high costs, and postoperative problems. Therefore, in order to solve the above problems, artificial tissues or organs with good biosafety and acceptable cost are of urgent need.…”